OVERVIEW

  PATENTS

  BIBLIOGRAPHY

 WHITE PAPERS

  WEB LINKS


Bibliography

The following articles are related to eNOS Pharmaceuticals and to the technology used in our products. Recently published articles are marked with a red asterisk (*).

•   Dalkara, T., Morikawa, E., Panahian, N., and Moskowitz, M. A. (1994) Blood flow-dependent functional recovery in a rat model of focal cerebral ischemia. Am J Physiol 267: H678-H683.

•   Dirnagl U, Iadecola C, Moskowitz MA. (1999) Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 22: 391-397.

•   Endres, Matthias, Laufs, Ulrich, Huang, Zhihong, Nakamura, Tadashi, Huang, Paul, Moskowitz, Michael A., and Liao, James A. (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci 95: 8880-8885.

*   Kaesemeyer WH, Caldwell RW.(2000) Atherosclerosis and nitric oxide production. Circulation. 2000 Sep 12;102(11):E90.

*   Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW. (2000) Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions.J Am Coll Cardiol. 1999 Jan;33(1):234-41.

*   Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Bohm M. (2000) Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation. Dec 19;102(25):3104-10.

*   Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Bohm M, Schoen FJ, Moskowitz MA, Liao JK. (2000) Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest. Jul;106(1):15-24.

•   Laufs U, La Fata V, Plutzky J, Liao JK. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.. Circulation. 1998 Mar 31;97(12):1129-35.

*   Laufs U, Liao JK. (2000) Direct vascular effects of HMG-CoA reductase inhibitors.. Trends Cardiovasc Med. 2000 May;10(4):143-8.

•   Laufs, Ulrich, La Fata, Vito, Plutzky, Jorge, and Liao, James A. (1998) Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors. Circulation 97: 1129-1135.

•   Laufs, Ulrich, La Fata, Vito, and Liao, James A. (1997) Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase. J Biol Chem 272: 31725-31729.

•   Ma, J., Ayata, C., Huang, P., Fishman, M.C., and Moskowitz, M. A. (1996) Regional cerebral blood flow response to vibrissal stimulation in mice lacking type I NOS gene expression. Am J Physiol 270: H1085-H1090.

*   Mital S, Zhang X, Zhao G, Bernstein RD, Smith CJ, Fulton DL, Sessa WC, Liao JK, Hintze TH. (2000) Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs. Am J Physiol Heart Circ Physiol. Dec;279(6):H2649-57.

*   Mital S, Magneson A, Loke KE, Liao J, Forfia PR, Hintze TH. (2000) Simvastatin acts synergistically with ACE inhibitors or amlodipine to decrease oxygen consumption in rat hearts. J Cardiovasc Pharmacol. Aug;36(2):248-54.

•   Morikawa, Eiharu, Huang, Zhihong, and Moskowitz, Michael A. (1992) L-Arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am J Physiol 263: H1632-H1635.

•   Morikawa, Eiharu, Moskowitz, Michael A., Huang, Zhihong, Yoshida, Tazuka, Irikura, Katsumi, and Dalkara, Turgay. (1994) L-Arginine Infusion Promotes Nitric Oxide-Dependent Vasodilation, Increase Regional Cerebral Blood Flow, and Reduces Infarction Volume in the Rat. Stroke 25: 429-435.

•   Morikawa, Eiharu, Rosenblatt, S., and Moskowitz, Michael A. (1992) L-Arginine dilates rat pial arterioldes by nitric oxide-dependent mechanism and increases blood flow during focal cerebral ischemia. Br J Pharmacol 107: 905-907.

*   Yamada M, Huang Z, Dalkara T, Endres M, Laufs U, Waeber C, Huang PL, Liao JK, Moskowitz MA. (2000) Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J Cereb Blood Flow Metab. Apr;20(4):709-17.


Home | Company | Resources | Contact
Copyright © 2001-2003 eNOS Pharmaceuticals
All rights reserved worldwide.